Literature DB >> 23316778

Transcutaneous vaccines--current and emerging strategies.

Sachiko Hirobe1, Naoki Okada, Shinsaku Nakagawa.   

Abstract

INTRODUCTION: Vaccination, which is the major fundamental prophylaxis against illness and death from infectious disease, has greatly contributed to the global improvement of human health. However, the disadvantages of conventional injection systems hamper the delivery of vaccination technologies to developing countries. The imminent practice of easy-to-use vaccination methods is expected to overcome certain issues associated with injectable vaccinations. One innovative method is the transcutaneous immunization (TCI) system. AREAS COVERED: Two major strategies for TCI are discussed in this review. One is to promote antigen permeation of the skin barrier by patch systems or nanoparticles. The other is the delivery of antigens into the skin by electroporation and microneedles in order to physically overcome the skin barrier. Moreover, adjuvant development for TCI is discussed. EXPERT OPINION: Many different approaches have been developed for TCI, which have the potential to be effective, easy-to-use and painless methods of vaccination. However, in practical terms, the guidelines concerning the manufacturing processes and clinical trial evaluation of the procedures have not kept pace with the development of these novel formulations. The accumulation of information regarding skin characteristics and the properties of TCI devices will help refine TCI system development guidelines and thus lead to the improvement of transcutaneous vaccination.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23316778     DOI: 10.1517/17425247.2013.760542

Source DB:  PubMed          Journal:  Expert Opin Drug Deliv        ISSN: 1742-5247            Impact factor:   6.648


  8 in total

1.  Local Delivery of the Toll-Like Receptor 9 Ligand CpG Downregulates Host Immune and Inflammatory Responses, Ameliorating Established Leishmania (Viannia) panamensis Chronic Infection.

Authors:  Allison K Ehrlich; Olga L Fernández; Daniel Rodriguez-Pinto; Tiago M Castilho; Maria J Corral Caridad; Karen Goldsmith-Pestana; Nancy Gore Saravia; Diane McMahon-Pratt
Journal:  Infect Immun       Date:  2017-02-23       Impact factor: 3.441

Review 2.  Nanocarriers for Skin Applications: Where Do We Stand?

Authors:  Neha Tiwari; Ernesto Rafael Osorio-Blanco; Ana Sonzogni; David Esporrín-Ubieto; Huiyi Wang; Marcelo Calderón
Journal:  Angew Chem Int Ed Engl       Date:  2021-10-01       Impact factor: 16.823

Review 3.  Is There an Optimal Formulation and Delivery Strategy for Subunit Vaccines?

Authors:  Sharan Bobbala; Sarah Hook
Journal:  Pharm Res       Date:  2016-07-05       Impact factor: 4.580

4.  Development of Novel Faster-Dissolving Microneedle Patches for Transcutaneous Vaccine Delivery.

Authors:  Akihiko Ono; Sayami Ito; Shun Sakagami; Hideo Asada; Mio Saito; Ying-Shu Quan; Fumio Kamiyama; Sachiko Hirobe; Naoki Okada
Journal:  Pharmaceutics       Date:  2017-08-03       Impact factor: 6.321

5.  Size-dependent penetration of nanoemulsions into epidermis and hair follicles: implications for transdermal delivery and immunization.

Authors:  Rui Su; Wufa Fan; Qin Yu; Xiaochun Dong; Jianping Qi; Quangang Zhu; Weili Zhao; Wei Wu; Zhongjian Chen; Ye Li; Yi Lu
Journal:  Oncotarget       Date:  2017-06-13

Review 6.  Lipid-Based Particles: Versatile Delivery Systems for Mucosal Vaccination against Infection.

Authors:  Blaise Corthésy; Gilles Bioley
Journal:  Front Immunol       Date:  2018-03-07       Impact factor: 7.561

Review 7.  Dissolving and biodegradable microneedle technologies for transdermal sustained delivery of drug and vaccine.

Authors:  Xiaoyun Hong; Liangming Wei; Fei Wu; Zaozhan Wu; Lizhu Chen; Zhenguo Liu; Weien Yuan
Journal:  Drug Des Devel Ther       Date:  2013-09-04       Impact factor: 4.162

8.  Lower-Sized Chitosan Nanocapsules for Transcutaneous Antigen Delivery.

Authors:  Juan I Bussio; Carla Molina-Perea; José Vicente González-Aramundiz
Journal:  Nanomaterials (Basel)       Date:  2018-08-26       Impact factor: 5.076

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.